|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Apr―14 |
Increase in hypoglycaemia and hyperglycaemia in people with diabetes admitted to hospital during COVID-19 pandemic |
Yue Ruan, Luca Mercuri, Dimitri Papadimitriou, Algirdas Galdikas, Gail Roadknight, Jim Davies, et al. (+4) Ben Glampson, Erik Mayer, Neil E. Hill, Rustam Rea |
2 |
[GO] |
2023―Jan―03 |
Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature |
Ana Realista Pedrosa, Diana Cruz Martins, Manfredi Rizzo, José Silva-Nunes |
3 |
[GO] |
2022―Dec―05 |
Type 1 diabetes outpatient care and treatment effectiveness during COVID-19: A single-center cohort study |
Michał Kania, Paulina Suduł, Konrad Mazur, Zlata Chaykivska, Mateusz Fiema, Marianna Kopka, et al. (+8) Małgorzata Kostrzycka, Magdalena Wilk, Jerzy Hohendorff, Beata Kieć-Wilk, Tomasz Klupa, Przemysław Witek, Barbara Katra, Maciej T. Malecki |
4 |
[GO] |
2022―Nov―28 |
Effect of the first and second COVID-19 associated lockdown on the metabolic control of patients with type 2 diabetes in Greece |
Eleftheria Papachristoforou, Stavros Liatis, Ourania Psoma, Aikaterini Kountouri, Vaia Lambadiari, Vasilis Tsimihodimos |
5 |
[GO] |
2022―Nov―08 |
Access to care by medicare beneficiaries in the U.S. with diabetes and multiple chronic conditions during the COVID-19 pandemic |
John M. Clements |
6 |
[GO] |
2022―Aug―13 |
COVID-19-associated Mucormycosis: A clinico-epidemiological study |
Jaya Chakravarty, Munesh Kumar Gupta, Ragini Tilak, Rajesh kumar, Rajendra Prasad Maurya, Nilesh Kumar, et al. (+9) Susheel Kumar Agarwal, Shiva S, Naresh Kumar Sharma, Neeraj Kumar Dhiman, Vishambhar Singh, Ashish verma, Tuhina Banerjee, Neeraj Kumar Agarwal, Ravi Shankar Prasad |
7 |
[GO] |
2022―Feb―07 |
Covid-19: A new cause of “provoked” A-β+ Ketosis-Prone Diabetes |
Ruchi Gaba, Ashok Balasubramanyam |
8 |
[GO] |
2022―Feb―04 |
Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes |
Sara J. Cromer, Caitlin Colling, Daria Schatoff, Michael Leary, Maria I. Stamou, Daryl J. Selen, et al. (+2) Melissa S. Putman, Deborah J. Wexler |
9 |
[GO] |
2021―Dec―09 |
Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-β+ KPD (ketosis-prone diabetes): A prospective study from Eastern India |
Riddhi Das Gupta, Avica Atri, Sunetra Mondal, Abhishek Bhattacharjee, Ramprasad Garai, Arindam Kumar Hazra, et al. (+4) Brojen Choudhury, Dhriti Sundar Dutta, Moushumi Lodh, Arunangshu Ganguly |
10 |
[GO] |
2021―Sep―28 |
Emotional burden and care of adults with type 1 diabetes during the COVID-19 pandemic in Brazilian regions |
Mônica S.V.M. Silveira, Elizabeth João Pavin, Edimariz Buin Cardoso, Paulo Fanti, Samereh Abdoli |
11 |
[GO] |
2021―May―28 |
Preadmission Predictors of Severe COVID-19 in Patients with Diabetes Mellitus |
Alpana P. Shukla, Beverly G. Tchang, Tiffany Lam, Ian Steller, I.I. Samir Touhamy, Gulce Askin, et al. (+6) Felicia A. Mendelsohn Curanaj, Jane J. Seley, Daniel Lorber, Monika M. Safford, Louis J. Aronne, Laura C. Alonso |
12 |
[GO] |
2021―Apr―19 |
Pharmacological management of COVID-19 in Type 2 Diabetes |
Antonio Ceriello, Francesco Prattichizzo |
13 |
[GO] |
2021―Jan―20 |
Psychosocial health in people with diabetes during the first three months of the COVID-19 pandemic in Denmark |
Kristoffer Panduro Madsen, Ingrid Willaing, Naja Hulvej Rod, Tibor V. Varga, Lene Eide Joensen |
14 |
[GO] |
2020―Nov―26 |
Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus |
Yangyang Cheng, Ling Yue, Zhiyang Wang, Junxia Zhang, Guangda Xiang |
15 |
[GO] |
2020―Nov―26 |
Impact of obesity on COVID-19 patients |
Wanqi Yu, Kristen E. Rohli, Shujuan Yang, Peng Jia |
16 |
[GO] |
2020―Oct―07 |
The Early Impact Of The COVID-19 Pandemic On Adults With Type 1 Or Type 2 Diabetes: A National Cohort Study |
Lawrence Fisher, William Polonsky, Adijat Asuni, Yasmin Jolly, Danielle Hessler |
17 |
[GO] |
2020―Oct―07 |
Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes |
Ourania Psoma, Eleftheria Papachristoforou, Aikaterini Kountouri, Kostantinos Balampanis, Athena Stergiou, Vaia Lambadiari, et al. (+2) Stavros Liatis, Vasilis Tsimihodimos |
18 |
[GO] |
2020―Aug―26 |
Anti-inflammatory properties of antidiabetic drugs: a “promised land” in the COVID-19 era? |
Niki Katsiki, Ele Ferrannini |
19 |
[GO] |
2020―Jul―06 |
COVID-19 in people living with diabetes: An international consensus |
A.E. Caballero, A. Ceriello, A. Misra, P. Aschner, M.E. McDonnell, M. Hassanein, et al. (+3) L. Ji, J.C. Mbanya, V.A. Fonseca |
20 |
[GO] |
2020―Jun―29 |
Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes |
Qianhui Zhang, Yanhong Wei, Min Chen, Qianqian Wan, Xiaoqi Chen |
21 |
[GO] |
2020―May―22 |
COVID-19 and diabetes: The why, the what and the how |
Sarah Cuschieri, Stephan Grech |
22 |
[GO] |
2020―May―15 |
COVID-19 and diabetes: No time to drag our feet during an untimely pandemic |
Ioannis Kyrou, Tim Robbins, Harpal S. Randeva |
23 |
[GO] |
2020―May―14 |
Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China |
Fenghua Tao, Xiaoyan Tang, Hai Tao, Yue Luo, Hui Cao, Wei Xiang, et al. (+2) Yingchun Zhao, Lin Jin |